Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SOPHiA GENETICS SA - Ordinary Shares (NQ:SOPH)

7.350 +0.050 (+0.68%)
Delayed Quote Updated: 10:31 AM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about SOPHiA GENETICS SA - Ordinary Shares

< Previous 1 2 3 4 Next >
News headline image
Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
When Unusual Volume Isn't Noise: 3 Small-Caps Sending Signals ↗
Canada Goose, Capital Clean Energy Carriers and SOPHiA Genetics have each seen unusual trading volume recently, driven by tariffs, LNG demand, and a strong earnings beat, respectively. 
Via MarketBeat
Topics Earnings World Trade
News headline image
SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript ↗
Revenue jumped 27% as platform volume surged and biopharma partnerships accelerated. 
Via The Motley Fool
Topics Artificial Intelligence Earnings
SOPHiA GENETICS (NASDAQ:SOPH) Beats Q2 Revenue Estimates, Shares Rise Despite Wider Loss ↗
Via Chartmill
SOPHiA GENETICS (NASDAQ:SOPH) Q1 Revenue Beats Estimates but Earnings Miss Sparks Pre-Market Decline ↗
Via Chartmill
Topics Earnings
News headline image
SOPHiA GENETICS Q2 Earnings Call Highlights ↗
SOPHiA GENETICS (NASDAQ:SOPH) reported second-quarter revenue growth of 27% and raised its full-year revenue outlook, as the precision medicine software company cited accelerating U.S. adoption, liquid... 
Via MarketBeat
Topics Earnings
News headline image
SOPHiA Genetics (SOPH) Q1 2026 Earnings Transcript ↗
SOPHiA Genetics (SOPH) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property
News headline image
SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript ↗
SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript 
Via The Motley Fool
SOPHiA GENETICS SA (NASDAQ:SOPH) Reports Mixed Q4 2025 Results with Revenue Beat and EPS Miss ↗
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2025 ↗
 
Via Benzinga
News headline image
Exploring Sophia Genetics's Earnings Expectations ↗
 
Via Benzinga
News headline image
Zscaler To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2025 Earnings: Revenue Beat and Raised Guidance Fuel Pre-Market Rally ↗
SOPHiA GENETICS Q3 2025 results beat revenue estimates and the company raised its full-year 2025 outlook, driving positive investor sentiment. 
Via Chartmill
News headline image
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores ↗
Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge Stock Rankings. 
Via Benzinga
News headline image
Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI
San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
SOPHiA GENETICS SA (NASDAQ:SOPH) Beats Q2 2025 Earnings Estimates, Shares Jump in Pre-Market Trading ↗
SOPHiA GENETICS beats Q2 2025 estimates with $18.32M revenue and $0.33 EPS, driving shares up 5.45% in pre-market trading. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
SOPH Stock Earnings: Sophia Genetics Beats EPS, Misses Revenue for Q2 2024 ↗
SOPH stock results show that Sophia Genetics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Earnings Scheduled For March 4, 2025 ↗
 
Via Benzinga
News headline image
SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting
Shareholders adopt all proposals at Annual General Meeting 
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
News headline image
Why Nvidia Stock Investors Should Be Excited About an Upcoming IPO ↗
CoreWeave, a company backed by Nvidia, is preparing to go public in 2025. 
Via The Motley Fool
News headline image
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
SOPH Stock Earnings: Sophia Genetics Beats EPS, Beats Revenue for Q1 2024 ↗
SOPH stock results show that Sophia Genetics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
SOPHiA GENETICS Reports First Quarter 2024 Results
Consistent Operational Execution; Robust New Business Momentum; Guidance Reaffirmed 
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.